As the TME contains various immune system components, HNSCC prognosis cannot be absolutely defined by a single factor, resulting in the relatively low performance (C-index) of CD200R1 and other clinical factors in our study. The gene discussed is CD200R1; the disease is head and neck squamous cell carcinoma.